Eszopiclone



- TRADE NAMES: Imovane (Sanofi-Aventis); Lunesta (Sunovion); Zimovane (Sanofi-Aventis)
- INDICATIONS: Insomnia
- CLASS: Hypnotic, non-benzodiazepine
- HALF-LIFE: 6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Antifungals, Cimetidine, CNS depressants, Conivaptan, CYP3A4 inhibitors and inducers, Dasatinib, Deferasirox, Droperidol, Erythromycin, Ethanol, Flumazenil, Ketoconazole, Levomepromazine, Lorazepam, Nefazodone, Nelfinavir, Olanzapine, Rifampin, Ritonavir, St John's Wort, Telithromycin, Tricyclic antidepressants, Valerian, Voriconazole
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric